Investigative Ophthalmology & Visual Science Cover Image for Volume 62, Issue 8
June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of the vitreoretinal interface in eyes with diabetic retinopathy using a 23 mm wide-field OCT
Author Affiliations & Notes
  • Takao Hirano
    Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Yoshiaki Chiku
    Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Ken Hoshiyama
    Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Toshinori Murata
    Shinshu Daigaku, Matsumoto, Nagano, Japan
  • Footnotes
    Commercial Relationships   Takao Hirano, None; Yoshiaki Chiku, None; Ken Hoshiyama, None; Toshinori Murata, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1912. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Takao Hirano, Yoshiaki Chiku, Ken Hoshiyama, Toshinori Murata; Evaluation of the vitreoretinal interface in eyes with diabetic retinopathy using a 23 mm wide-field OCT. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1912.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : It is well known that there is a high prevalence of vitreoretinal interface abnormalities, such as epiretinal membrane and incomplete vitreoretinal separation, in patients with diabetic retinopathy (DR). Xephilio OCT-S1 (Canon) can capture a swept source OCT image up to 23 mm with a single acquisition and is expected to provide detailed evaluation of the vitreoretinal interface over a wide field. We aimed to evaluate the vitreoretinal interface with wide-field OCT in eyes with DR.

Methods : This cross-sectional study included 193 eyes of 112 patients (mean [SD] age, 63[12] years; 41 females, 71 males) with DR. All patients underwent 23 mm OCT imaging using OCT-S1 through the fovea, with the focus placed at -3.0 diopter to the vitreous cavity, to visualize the vitreoretinal interface in more detail. All eyes staged by diabetic retinopathy severity were classified into posterior vitreous detachment (PVD) stages and categorized by the presence or absence of vitreoretinal interface abnormalities.

Results : The cohort of eyes with no DR (16 eyes; mean age: 68[14] years) consisted included seven eyes with stage 2 PVD, nine eyes with stage 4 PVD, and no eyes with vitreoretinal interface abnormalities. The eyes with non-proliferative diabetic retinopathy (NPDR; 81eyes; mean age: 65[11] years) included eight eyes with stage 0 PVD, 11 eyes with stage 1 PVD, 13 eyes with stage 2 PVD, six eyes with stage 3 PVD, and 43 eyes with stage 4 PVD. Of these, 23% had vitreoretinal interface abnormalities. The eyes with PDR (96 eyes; mean age: 59[11] years) included eight eyes with stage 0 PVD, seven eyes with stage 1 PVD, 21 eyes with stage 2 PVD, 24 eyes with stage 3, and 36 eyes with stage 4 PVD, of which 43% had vitreoretinal interface abnormalities.

Conclusions : Although there was no significant difference in the composition of the PVD stage according to DR severity, the proportion of vitreoretinal interface abnormalities increased with severity.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×